Press Release
Akebia Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
The options have an exercise price of $14.78 per share, which is equal to the closing price of Akebia’s common stock on the grant date. Each stock option vests over four years, with 25% of the shares vesting on the first anniversary of the grant date and the remaining 75% of shares vesting quarterly thereafter, in each case, subject to the new employee’s continued service with the company. Each stock option has a ten-year term and is subject to the terms and conditions of the company’s 2016 Inducement Award Program and a stock option agreement covering the grant.
About Akebia Therapeutics
View source version on businesswire.com: http://www.businesswire.com/news/home/20180202005020/en/
Source:
Akebia Therapeutics
John Garabo, 617-844-6130
Director,
Corporate Communications
jgarabo@akebia.com
Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142
+1 617.871.2098 phone
+1 617.871.2099 fax